Veterinary Molecular Diagnostics Market Trends | Segmentation, Outlook, Industry Report to 2032
The global Veterinary Molecular Diagnostics market In 2022, the market for veterinary molecular diagnostics is projected to be worth US$182.1 million. The overall demand for veterinary molecular diagnostics is anticipated to increase at a CAGR of 6.84% between 2022 and 2032, reaching a total of about US$ 352.8 Million by 2032 due to the use of numerous testing panels and the growing consolidation in the veterinary diagnostics industry.
Factors such as the growing pet animal population around the
globe, increased animal health spending and advancements in veterinary
molecular diagnostics are expected to propel the growth of the veterinary
molecular diagnostics market over the analysis period.
Developments in the animal farming sector and changing
societal attitude toward pet animals have resulted in an increased demand for
fast and reliable diagnostic techniques. Molecular diagnostics possess the
potential to address this growing demand.
Request Sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-6742
As of 2018, more than 60% of the US population owned a
pet/companion animal. There is an increasing trend of treating pets as family
members, which has increased the healthcare demands for veterinary
applications. The increasing pet population is one of the reasons for the
rising health expenditure on animals, globally.
As per the estimates of the American Pet Products
Association, the total American pet industry expenditure is expected to reach
USD 75.38 billion by end 2019, up from USD 72.56 billion in 2018. The rise in
animal health expenditure is expected to drive the growth of the veterinary
molecular diagnostics market, as a significant portion of pet owners are
expected to use advanced diagnostic modalities for animals, for various disease
conditions.
Furthermore, there is an increase in the livestock
population, owing to the huge demand for animal-derived products. This is
expected to increase the demand for molecular diagnostic tests in the next
coming years.
The Veterinary Molecular Diagnostics Market in the
US is expected to accumulate the highest market share of 34.6% in
2022. The United States is expected to dominate the market, attributed to
factors, such as rising pet adoption and increasing per capita animal
healthcare expenditure. In addition, the rise in the prevalence of various
animal diseases and injuries is another major factor that is anticipated to
fuel the market growth during the forecast period.
Talk to Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-6742
The high growth in the number of veterinary practitioners
and rise in income levels in developed economies is amongst the important
factors intensifying the growth and demand of veterinary molecular
diagnostics market. In addition, the increasing demand for pet insurance
and growing animal health expenditure is also contributing to the growth in the
global market during the forecast period.
In addition, the increasing demand for animal-derived food
products and rising incidence of animal zoonotic diseases are also enhancing
the growth of the market. Likewise, the high growth in companion animal
population is also lifting the market growth in the forthcoming years.
Key Takeaways from the Market Study
- Global
Veterinary Molecular Diagnostics Market was valued at US$ 182.1 Mn
by 2022-end
- From
2017 to 2021, the market demand expanded at a CAGR of 7.3%
- By
Product Type, the PCR Kits segment of the Veterinary Molecular Diagnostics
Market constitutes the bulk of the market with a market share of 50.8%
- By
Species Type, the Livestock Animals segment dominates the market with a
share of 71.0%
- From
2022 to 2032, Veterinary Molecular Diagnostics sales are expected to
flourish at a CAGR of 6.84%.
- By
2032, the market value of Veterinary Molecular Diagnostics is expected to
reach US$ 352.8 Mn.
“Factors such as the rising per capita animal
healthcare expenditure, coupled with rising pet adoption globally are
expected to escalate the growth of the Veterinary Molecular Diagnostics Market
over the analysis period”, remarks an FMI analyst.
Last few days to get reports at discounted prices, offer
expires soon!
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-6742
Competitive Landscape
Players in the global Veterinary Molecular Diagnostics
Market focus on expanding their global reach through various strategies, such
as; partnerships, collaborations, and partnerships. The players are also making
a significant investment in R&D to add innovations to their products which
would help them in strengthening their position in the global market. Some of
the recent developments among the key players are:
- In
April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer
Ingelheim’s Svanova product portfolio which helped INDICAL widen its
portfolio by adding 25 assays for livestock.
- In
April 2021, BioChek (Netherlands) opened a new office in Johannesburg,
South Africa.
- In
January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US),
this acquisition strengthened the company’s portfolio of point-of-care
digital cytology technology and telemedicine services.
- In
December 2020, NEOGEN Corporation (US) launched a preventative care DNA
screening tool for detecting genetic diseases in dogs.
- In
November 2020, NEOGEN Corporation (US) collaborated with Transnetyx Inc.
(US), this partnership helped NEOGEN to increase its presence in the
animal genomics and diagnostics market.
Key Players:
- bioMérieux
SA
- IDEXX
Laboratories, Inc.
- Neogen
Europe, Ltd.
- Veterinary
Molecular Diagnostics, Inc.
- Thermo
Fisher Scientific, Inc.
- ID-Vet,
Qiagen N.V.
Comments
Post a Comment